Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Clonidine hydrochloride
Drug ID BADD_D00503
Description Clonidine is an imidazole derivate that acts as an agonist of alpha-2 adrenoceptors.[A180559] This activity is useful for the treatment of hypertension, severe pain, and ADHD.[L7237,L7240,L7243,L7246] Clonidine was granted FDA approval on 3 September 1974.[L7237]
Indications and Usage May be used as an adjunct in the treatment of hypertension, as an epidural infusion as an adjunct treatment in the management of severe cancer pain that is not relieved by opiate analgesics alone, for differential diagnosis of pheochromocytoma in hypertensive patients, prophylaxis of vascular migraine headaches, treatment of severe dysmenorrhea, management of vasomotor symptoms associated with menopause, rapid detoxification in the management of opiate withdrawal, treatment of alcohol withdrawal used in conjunction with benzodiazepines, management of nicotine dependence, topical use to reduce intraocular pressure in the treatment of open-angle and secondary glaucoma and hemorrhagic glaucoma associated with hypertension, and in the treatment of attention-deficit hyperactivity disorder (ADHD).
Marketing Status Prescription; Discontinued
ATC Code C02AC01; N02CX02; S01EA04
DrugBank ID DB00575
KEGG ID D00604
MeSH ID D003000
PubChem ID 20179
TTD Drug ID D03SKR
NDC Product Code 29300-136; 53002-4940; 53002-4941; 49452-2147; 59212-658; 60760-057; 67296-1196; 70934-851; 50090-3151; 10135-708; 63187-419; 68180-606; 61919-718; 50090-2775; 43353-316; 50090-1909; 71034-001; 59746-668; 63629-1328; 42413-0053; 50090-5089; 60760-178; 71205-570; 66267-061; 0395-8132; 62332-054; 67457-218; 55700-802; 79572-009; 68071-4041; 68382-601; 29300-137; 68788-7685; 50090-5105; 52935-0051; 71335-1624; 61919-605; 50090-5103; 68001-237; 43063-924; 43063-925; 68382-602; 81371-7005; 70518-1283; 70518-3162; 67046-327; 43547-567; 46708-306; 10135-709; 62332-056; 53002-4140; 63629-2318; 60429-431; 46708-308; 63629-7765; 76420-066; 63629-7652; 55700-704; 68071-4545; 61919-268; 43063-817; 71610-449; 66267-062; 71335-0050; 71335-0539; 71335-0121; 61919-266; 29300-468; 42291-148; 70771-1193; 46708-844; 63629-2317; 70518-0481; 68001-239; 68071-4094; 58118-0072; 68788-7145; 45865-797; 70934-752; 70518-3276; 70518-3350; 53747-010; 68071-4661; 63629-2319; 0228-2128; 70518-0350; 68001-238; 0143-9723; 72789-091; 71335-1495; 27241-108; 70518-1811; 66267-464; 51662-1210; 70518-1962; 71205-588; 68071-2631; 50090-1908; 29300-135; 70934-793; 71335-0777; 71205-218; 52817-180; 50090-1910; 62991-1422; 70934-226; 68071-3016; 63629-2316; 0615-2574; 58657-648; 52817-182; 58657-647; 68981-029; 68071-2210; 51927-2379; 60687-462; 0228-2129; 43547-566; 71335-0922; 63629-2314; 68071-4721; 61919-267; 43547-435; 68788-8163; 55154-2577; 50090-4360; 70518-1959; 0228-2127; 63629-1208; 55154-2576; 63629-2753; 58657-649; 52817-181; 67296-0685; 0615-2572; 63629-2315; 53002-4141; 0615-8272; 0143-9724; 68788-8080; 70518-3295; 70771-1194; 0228-4241; 71335-0915; 10135-710; 50090-5577; 51655-339; 60687-124; 68071-4601; 46708-307; 70934-271; 43547-565; 10370-257; 70518-1000; 38779-0561; 60687-113; 70518-0898; 62332-055
Synonyms Clonidine | Klofenil | Clofenil | Chlophazolin | Clonidine Dihydrochloride | Dihydrochloride, Clonidine | Clonidine Hydrochloride | Hydrochloride, Clonidine | Clonidine Monohydrochloride | Monohydrochloride, Clonidine | Clonidine Monohydrobromide | Monohydrobromide, Clonidine | ST-155 | ST 155 | ST155 | Gemiton | Hemiton | Isoglaucon | Klofelin | Clofelin | Clopheline | M-5041T | M 5041T | M5041T | Catapres | Catapresan | Catapressan | Dixarit
Chemical Information
Molecular Formula C9H10Cl3N3
CAS Registry Number 4205-91-8
SMILES C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl.Cl
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Adverse drug reactionDelta-type opioid receptorP41143T58992Not Available
Adverse drug reactionG protein-activated inward rectifier potassium channel 1P48549T38012Not Available
Adverse drug reactionKappa-type opioid receptorP41145T60693Not Available
AgranulocytosisMyeloperoxidaseP05164T23471Not Available
Drug level changedCytochrome P450 3A4P08684T37848Not Available
Drug level increasedCytochrome P450 1A2P05177Not AvailableNot Available
Drug level increasedCytochrome P450 2D6P10635T57392Not Available
Seizures (incl subtypes)G protein-activated inward rectifier potassium channel 1P48549T38012Not Available
Sinus tachycardiaG protein-activated inward rectifier potassium channel 1P48549T38012Not Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Dizziness24.06.02.007; 17.02.05.003; 02.01.02.004--
Dry eye06.08.02.001--
Dry mouth07.06.01.002--
Dyspnoea22.02.01.004; 02.01.03.002--
Dysuria20.02.02.002--
Electrocardiogram abnormal13.14.05.001--Not Available
Eye discharge06.04.05.001--Not Available
Eye irritation06.04.05.003--Not Available
Eyelid oedema06.04.04.004; 23.04.01.003; 10.01.05.001--Not Available
Eyelid retraction06.06.04.002--Not Available
Face oedema23.04.01.004; 10.01.05.002; 08.01.07.003--
Fatigue08.01.01.002--
Gynaecomastia05.05.02.003; 21.05.04.003--
Hallucinations, mixed19.10.02.007--Not Available
Headache17.14.01.001--
Hepatitis09.01.07.004--Not Available
Hyperaemia24.03.02.002--Not Available
Insomnia19.02.01.002; 17.15.03.002--
Keratitis06.04.02.002--
Keratopathy06.06.03.007--Not Available
Lacrimation increased06.08.02.004--
Liver function test abnormal13.03.01.013--Not Available
Loss of libido19.08.03.003--Not Available
Malaise08.01.01.003--
Muscle spasms15.05.03.004--
Myalgia15.05.02.001--
Nasal dryness22.04.03.002--Not Available
Nausea07.01.07.001--
Nervousness19.06.02.003--Not Available
Nightmare19.02.03.003--Not Available
The 2th Page    First    Pre   2 3 4    Next   Last    Total 4 Pages